BioTelemetry, Inc. Acquires Remote Patient Monitoring Platform from Centene Subsidiary
July 29 2020 - 8:00AM
BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical
technology company focused on the delivery of health information to
improve quality of life and reduce cost of care, today announced it
has acquired the On.Demand™ remote patient monitoring (RPM)
and coaching platform, operated by Envolve People Care, Inc., a
Centene Corporation subsidiary. This acquisition adds chronic
RPM and coaching solutions to BioTelemetry’s current suite of acute
care connected health products and services, focusing specifically
on diabetes, hypertension and chronic heart failure.
As part of this acquisition, and under the companies’ strategic
partnership agreement, BioTelemetry becomes the exclusive provider
of diabetes RPM services to Centene Medicaid members currently
utilizing, implementing or engaged to implement the platform in
2020. In addition to Centene, BioTelemetry will partner
externally with payor, provider and employer organizations to
improve health outcomes, reduce costs and eliminate waste using
On.Demand’s targeted monitoring and coaching interventions.
“We are excited to add On.Demand to our connected health
portfolio,” said Joseph H. Capper, President and CEO of
BioTelemetry. “This acquisition uniquely positions
BioTelemetry to deliver population health solutions at a time when
remote and telehealth options are increasingly important in
improving effectiveness across the healthcare continuum. We
are delighted to partner with an organization like Centene, which
has demonstrated a clear commitment to improving the lives of so
many people and communities.”
On.Demand is a mHealth solution that combines real-time
monitoring of biometric data with cellular- and web-based
technology, proactive and reactive health coaching, population
health reporting and customizable interventions. The platform
is designed to supplement a physician’s care plan by increasing
patient engagement, improving compliance and reducing costs.
It matches people to the clinical expertise and condition
management tools they need when they need them, providing
intervention and triage that helps bridge the gap between patient
visits. In addition, the platform also includes Alexa
Skill. On.Demand users are able to schedule coaching
appointments, access educational resources, set reminders, and
receive real-time assessments and immediate referrals for mental
and physical health needs.
BioTelemetry is the pioneer in patient care monitoring,
providing technology and services that enable healthcare providers
to monitor and diagnose patients and clinical research subjects
more efficiently, accurately and cost-effectively. Through
its connected health solutions, population health management
platform and support of some of the largest clinical trials,
BioTelemetry is advancing health and improving lives.
BioTelemetry’s suite of services and devices expand across
cardiac outpatient telemetry, diabetes, hypertension and weight
management.
About BioTelemetry BioTelemetry, Inc. is
the leading remote medical technology company focused on delivery
of health information to improve quality of life and reduce cost of
care. We provide remote cardiac monitoring, centralized core
laboratory services for clinical trials, remote blood glucose
monitoring and original equipment manufacturing that serves both
healthcare and clinical research customers. More information
can be found at www.gobio.com.
Heather C. GetzInvestor RelationsExecutive Vice
President, Chief Financial
Officer800-908-7103investorrelations@biotelinc.com
Amy M. KnappMedia RelationsVice President,
Corporate Communications813-277-8456amy.knapp@gobio.com
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2024 to Jul 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jul 2023 to Jul 2024